Annual Accounts Receivable
N/A
June 30, 2024
Summary
- IBIO annual accounts receivable is not available.
Performance
IBIO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- IBIO quarterly accounts receivable is not available.
Performance
IBIO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IBIO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
IBIO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
IBio Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $70.00 K(-92.8%) |
| Dec 2022 | - | $970.00 K(-8.1%) |
| Sep 2022 | - | $1.05 M(+5.5%) |
| Jun 2022 | $1.00 M(+134.7%) | $1.00 M(-0.4%) |
| Mar 2022 | - | $1.00 M(+804.5%) |
| Dec 2021 | - | $111.00 K(-46.4%) |
| Sep 2021 | - | $207.00 K(-51.4%) |
| Jun 2021 | $426.00 K(+468.0%) | $426.00 K(+10.1%) |
| Mar 2021 | - | $387.00 K(+115.0%) |
| Dec 2020 | - | $180.00 K(-40.0%) |
| Sep 2020 | - | $300.00 K(+300.0%) |
| Jun 2020 | $75.00 K(-22.7%) | $75.00 K(0.0%) |
| Mar 2020 | - | $75.00 K(-66.5%) |
| Dec 2019 | - | $224.00 K(+198.7%) |
| Sep 2019 | - | $75.00 K(-22.7%) |
| Jun 2019 | $97.00 K(+29.3%) | $97.00 K(-17.1%) |
| Mar 2019 | - | $117.00 K(-24.5%) |
| Dec 2018 | - | $155.00 K(+30.3%) |
| Sep 2018 | - | $119.00 K(+58.7%) |
| Jun 2018 | $75.00 K(-57.1%) | $75.00 K(-58.6%) |
| Mar 2018 | - | $181.00 K(+33.1%) |
| Dec 2017 | - | $136.00 K(-47.7%) |
| Sep 2017 | - | $260.00 K(+48.6%) |
| Jun 2017 | $175.00 K(-63.8%) | $175.00 K(+36.7%) |
| Mar 2017 | - | $128.00 K(+412.0%) |
| Dec 2016 | - | $25.00 K(-85.3%) |
| Sep 2016 | - | $170.00 K(-64.9%) |
| Jun 2016 | $484.00 K | $484.00 K(+6.6%) |
| Mar 2016 | - | $454.00 K(+124.8%) |
| Dec 2015 | - | $202.00 K(-57.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $480.00 K(+7.9%) |
| Jun 2015 | $445.00 K(+117.1%) | $445.00 K(+30.5%) |
| Mar 2015 | - | $341.00 K(-41.6%) |
| Dec 2014 | - | $584.00 K(>+9900.0%) |
| Sep 2014 | - | $0.00(-100.0%) |
| Jun 2014 | $205.00 K(-79.6%) | $205.00 K(-79.6%) |
| Mar 2014 | - | $1.01 M(0.0%) |
| Dec 2013 | - | $1.01 M(0.0%) |
| Sep 2013 | - | $1.01 M(0.0%) |
| Jun 2013 | $1.01 M(+186.9%) | $1.01 M(+158.1%) |
| Mar 2013 | - | $390.20 K(0.0%) |
| Dec 2012 | - | $390.20 K(0.0%) |
| Sep 2012 | - | $390.20 K(+11.2%) |
| Jun 2012 | $351.00 K(+2.0%) | $351.00 K(-5.6%) |
| Mar 2012 | - | $371.80 K(+59.0%) |
| Dec 2011 | - | $233.80 K(-27.0%) |
| Sep 2011 | - | $320.30 K(-6.9%) |
| Jun 2011 | $344.10 K(>+9900.0%) | $344.10 K(+470.6%) |
| Dec 2010 | - | $60.30 K(+8.5%) |
| Sep 2010 | - | $55.60 K(>+9900.0%) |
| Jun 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2010 | - | $9400.00(-38.2%) |
| Dec 2009 | - | $15.20 K(-92.6%) |
| Sep 2009 | - | $205.90 K(-1.9%) |
| Jun 2009 | $209.80 K(+99.1%) | $209.80 K(+10.6%) |
| Mar 2009 | - | $189.70 K(-42.0%) |
| Dec 2008 | - | $327.20 K(+7.5%) |
| Sep 2008 | - | $304.50 K(+188.9%) |
| Jun 2008 | $105.40 K(-27.7%) | $105.40 K |
| Jun 2007 | $145.70 K | - |
FAQ
- What is the all time high annual accounts receivable for iBio?
- What is the all time high quarterly accounts receivable for iBio?
What is the all time high annual accounts receivable for iBio?
iBio all-time high annual accounts receivable is $1.01 M
What is the all time high quarterly accounts receivable for iBio?
iBio all-time high quarterly accounts receivable is $1.05 M